Clinical impact of tumoral angiogenesis on renal cell carcinoma management: where do we stand?

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29201610.1080/23808993.2016.11819742-s2.0-85047459383https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/29209Drug DiscoveryGeneticsMolecular MedicinePharmacologyClinical impact of tumoral angiogenesis on renal cell carcinoma management: where do we stand?editorial